Is NMN or NR better for raising NAD+ levels?

Both effectively raise NAD+ levels. NMN may be slightly more direct (closer to NAD+ in the synthesis pathway), while NR has more published human clinical trial data. The practical difference may be small. Choose reputable, third-party tested products.

Are NAD+ IV drips worth the cost?

NAD+ IV infusions directly raise blood NAD+ levels but are expensive (£200-500+), time-consuming (2-4 hours), and the effects are temporary. Oral precursors (NMN/NR) may provide similar long-term NAD+ elevation at much lower cost, though head-to-head comparisons are lacking.

Can NAD+ reverse ageing?

Animal studies show NAD+ restoration can reverse some markers of ageing (mitochondrial function, DNA repair capacity). However, human evidence for anti-ageing effects is still limited. NAD+ decline is one of several hallmarks of ageing, and addressing it alone is unlikely to 'reverse' ageing.

Is NAD+ safe to take long-term?

Oral NMN/NR supplements appear safe in studies up to 12 months. Long-term data (5+ years) is lacking. The theoretical concern about supporting tumour metabolism has not been confirmed clinically but warrants monitoring. Consult a healthcare professional before long-term supplementation.

Fact-checked by the Peptide Authority Editorial Board · Last reviewed: 8 March 2026

Share:X Post LinkedIn

Longevity & Anti-Ageing•Updated 2026-03-08•5 min read

What Is NAD+? Benefits, Research & Safety

An essential coenzyme involved in cellular energy production and DNA repair, central to ageing research and available as IV infusions and oral precursor supplements.

Share:X Post LinkedIn

Also known as:

Nicotinamide Adenine Dinucleotide

NAD

Coenzyme I

DPN

CLimited human evidenceUK: Sold as 'research only' (UK)WADA: Low sport risk

UK summary: Not a peptide — a coenzyme. NMN and NR oral precursors are sold as supplements. NAD+ IV drip clinics are popular in the UK; clinical evidence for the marketed wellness outcomes is modest, and pricing is high (£200-500+ per drip).

Quick Facts

Overview

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, essential for fundamental biological processes including energy metabolism, DNA repair, gene expression regulation, and cellular signaling. While technically a dinucleotide rather than a peptide, NAD+ is extensively discussed alongside peptide therapies in longevity and anti-ageing contexts. NAD+ levels decline significantly with age—studies suggest a 50% reduction between ages 40 and 60. This decline is associated with mitochondrial dysfunction, accumulation of DNA damage, chronic inflammation ("inflammaging"), and many age-related diseases. The NAD+ longevity field was revolutionised by the work of David Sinclair and Leonard Guarente, who showed that NAD+-dependent enzymes called sirtuins (particularly SIRT1-7) regulate ageing pathways. Sirtuins require NAD+ as a cofactor, linking NAD+ depletion directly to accelerated ageing. NAD+ can be replenished through several approaches: - **IV NAD+ infusions:** Direct intravenous administration (expensive, time-consuming) - **Precursor supplementation:** NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are orally available precursors - **Lifestyle:** Exercise, caloric restriction, and circadian rhythm optimisation support NAD+ levels NAD+ IV therapy has become popular in longevity clinics worldwide. Oral precursors (particularly NMN) are widely available as supplements. While preclinical evidence is compelling, large-scale human clinical trials are still limited.

Evidence standards summary

NAD+ — evidence and risk at a glance

Twenty standard modules scored against the Peptide Authority evidence grading methodology. Missing modules indicate the field has not yet been characterised editorially — treat absences as uncertainty rather than reassurance.

01Evidence snapshot

CLimited human evidenceOverall grade against our evidence grading methodology.

Not a peptide — a coenzyme. NMN and NR oral precursors are sold as supplements. NAD+ IV drip clinics are popular in the UK; clinical evidence for the marketed wellness outcomes is modest, and pricing is high (£200-500+ per drip).

02Human evidence grade

CLimited human evidenceStrength of evidence from published human trials.

03Preclinical evidence grade

AStrong human evidenceAnimal-model and in-vitro evidence quality.

04Regulatory status

UK: NAD+ precursors (NMN, NR) are available as food supplements. IV NAD+ available at private clinics (not NHS-funded).
EU: NR is available as a supplement. NMN regulatory status varies by country—classified as Novel Food in some jurisdictions.
Notes: NAD+ and its precursors are not classified as medicines. IV NAD+ therapy is available privately but not evidence-based by NHS standards. NMN was briefly under FDA scrutiny in the US but remains available as a supplement. The field is rapidly evolving with ongoing clinical trials.

05Approved medical uses

None in the UK or EU as a finished medicine. (Or: not yet documented; treat as absence rather than approval.)

06Unapproved / promotional claims

Reverses biological ageing.
Treats long COVID.
Cures chronic fatigue.

07Common internet claims

Marketed by IV-drip clinics at £200-500+ per infusion.
NMN / NR supplements widely sold as longevity precursors.

08Claim vs evidence

Claim	Evidence	Human evidence?	Regulatory concern	Safer wording
“Reverses biological ageing”	E	No	High	Animal studies show NAD restoration affects ageing-related markers; human ageing-reversal claims are not supported.
“IV drips are more effective than oral NMN”	D	Limited	Moderate	IV NAD+ raises blood NAD acutely; whether this drives the wellness outcomes claimed is not established. Oral NMN/NR is far cheaper for sustained elevation.
“Safe long-term”	C	Limited	Moderate	Short-term safety data are encouraging; long-term (5+ years) human safety is not established.

09Safety uncertainty score

Moderate

Safety profile partly characterised; some signals from observational or preclinical data.

10Known adverse signals

IV NAD+: flushing, nausea, chest pressure during infusion.
Theoretical cancer-pathway concerns with sustained NAD+ elevation (mixed signal).
Sterility issues with grey-market IV preparations.

11Drug-interaction uncertainty

Moderate

Some interaction data published; check with a prescriber for your specific medicines.

12Anti-doping status

WADA: Low sport riskWADA strict-liability framing applies.

13UK legal position

UK: Sold as 'research only' (UK)

NAD+ precursors (NMN, NR) are available as food supplements. IV NAD+ available at private clinics (not NHS-funded).

14EU legal position

NR is available as a supplement. NMN regulatory status varies by country—classified as Novel Food in some jurisdictions.

15What this page cannot tell you

Whether IV NAD+ produces any longevity / wellness benefit beyond the placebo and infusion-experience effect.
Long-term safety of sustained pharmacological NAD+ elevation.

16Last reviewed

Last reviewed: 8 March 2026

Next review due: 8 March 2027

Spotted an error or something out of date? Send a correction.

17Citation quality score

BModerate human evidenceQuality of the sources we cite, graded against the evidence grading methodology.

18Research gaps

Phase 3 longevity / disease-prevention outcome trials absent.
Oral vs IV comparative-effectiveness for any defined outcome.

19Safer alternatives / established care pathways

Exercise, sleep, Mediterranean diet — the evidence-based longevity interventions.
NHS investigation for genuine chronic fatigue / long-COVID concerns.

20Doctor discussion prompts

Questions to ask a qualified clinician

These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.

Is there a clinical reason to elevate NAD+ for my specific situation, or is this a wellness experiment?

Discovery & History

NAD+ was discovered in 1906 by Arthur Harden and William Young as a factor enhancing the rate of fermentation in yeast extracts. Hans von Euler-Chelpin determined its structure and shared the 1929 Nobel Prize with Harden for this work. The role of NAD+ in cellular metabolism was established through mid-20th century biochemistry, with its function in redox reactions (NAD+/NADH) becoming a cornerstone of metabolic understanding. The modern NAD+ renaissance began in the 2000s with two key discoveries: - Leonard Guarente's work showing that sirtuins (NAD+-dependent deacetylases) regulate ageing in yeast, worms, and flies - David Sinclair's research demonstrating that boosting NAD+ levels with precursors like NMN could reverse aspects of ageing in mice The 2013 landmark paper by Gomes et al. showed that declining NAD+ levels drove age-related mitochondrial dysfunction and that NMN supplementation could reverse this. This sparked enormous research interest and commercial development. Clinical trials of NAD+ precursors in humans began around 2017, with NR (Niagen) and NMN studies showing safety and ability to raise NAD+ levels. The human evidence base continues to grow rapidly.

Mechanism of Action

NAD+ is involved in hundreds of enzymatic reactions: **Sirtuin Activation** NAD+-dependent deacetylases crucial for longevity: - SIRT1: Metabolic regulation, DNA repair, inflammation control - SIRT3: Mitochondrial function and antioxidant defence - SIRT6: Genomic stability and telomere maintenance - All sirtuins require NAD+ as an essential cofactor - NAD+ decline reduces sirtuin activity, accelerating ageing **Cellular Energy Production** Central role in metabolism: - NAD+/NADH redox pair essential for glycolysis - Critical for mitochondrial electron transport chain - Required for fatty acid oxidation - Supports cellular ATP production **DNA Repair** Via PARP enzymes: - PARP1 and PARP2 use NAD+ for DNA strand break repair - Chronic DNA damage increases PARP activity - Excessive PARP activation depletes NAD+ pools - Creates a vicious cycle of damage and depletion with ageing **CD38 and NAD+ Consumption** Age-related NAD+ decline mechanism: - CD38 (a NADase) increases with age and inflammation - CD38 is a major consumer of NAD+ in ageing tissues - Inhibiting CD38 may help preserve NAD+ levels - Represents a therapeutic target for NAD+ restoration

Researched Benefits

Based on preclinical and clinical research findings:

1
Restored mitochondrial function in aged mice (preclinical)
2
Improved insulin sensitivity and metabolic parameters (animal studies)
3
Enhanced DNA repair capacity (preclinical)
4
Cardiovascular protection in animal models
5
Neuroprotection and cognitive improvement (animal studies)
6
Safe elevation of blood NAD+ levels in humans (clinical trials of NMN/NR)
7
Potential exercise performance enhancement (limited human data)

Claim vs Evidence

How popular claims about NAD+ stack up against the current research, graded using our public evidence grading methodology.

Claim	Evidence	Human evidence?	Regulatory concern	Safer wording
“Reverses biological ageing”	E	No	High	Animal studies show NAD restoration affects ageing-related markers; human ageing-reversal claims are not supported.
“IV drips are more effective than oral NMN”	D	Limited	Moderate	IV NAD+ raises blood NAD acutely; whether this drives the wellness outcomes claimed is not established. Oral NMN/NR is far cheaper for sustained elevation.
“Safe long-term”	C	Limited	Moderate	Short-term safety data are encouraging; long-term (5+ years) human safety is not established.

Theoretical Dosing & Protocols

⚠️ Educational Only: The following information is derived from research literature and is not a prescription or recommendation. No standardised human dosing exists. Always consult a qualified healthcare professional.

Theoretical Dosage	IV NAD+: 250-750mg per infusion. Oral NMN: 250-1000mg daily. Oral NR: 300-1000mg daily.
Frequency	IV: weekly to monthly sessions. Oral precursors: daily supplementation.
Duration	Ongoing; NAD+ levels decline without continued supplementation
Notes	NAD+ IV infusions are available at longevity clinics (expensive, £200-500+ per session). Oral precursors (NMN, NR) are available as food supplements without prescription. Quality varies significantly between products. Long-term human efficacy data for anti-ageing is still limited.

Administration Routes

Routes studied in research settings (educational only):

Intravenous infusion (IV NAD+)
Oral (NMN and NR precursor supplements)
Sublingual (some NMN formulations)
Intranasal (experimental)

Half-Life	Stability
NAD+ itself has a half-life of hours in circulation; tissue NAD+ pools are maintained by continuous synthesis	IV NAD+ solutions prepared fresh; NMN/NR supplements stable as dry powder

Safety Profile & Known Risks

Commonly Reported Side Effects

IV NAD+: nausea, cramping, chest tightness during infusion
Flushing and warmth (IV)
Headache
Mild GI discomfort with oral precursors
IV infusions can be uncomfortable (2-4 hour duration)

Rare Risks & Concerns

Theoretical concern about supporting tumour metabolism
Interaction with NAD+-dependent drug metabolism
Limited long-term safety data for high-dose supplementation
IV complications (standard IV risks)

Contraindications

Active cancer (theoretical concern about fuelling tumour metabolism)
Pregnancy and breastfeeding (insufficient safety data)
Concurrent use of NAD+-affecting medications

UK & EU Regulatory Context

🇬🇧 United Kingdom

NAD+ precursors (NMN, NR) are available as food supplements. IV NAD+ available at private clinics (not NHS-funded).

🇪🇺 European Union

NR is available as a supplement. NMN regulatory status varies by country—classified as Novel Food in some jurisdictions.

NAD+ and its precursors are not classified as medicines. IV NAD+ therapy is available privately but not evidence-based by NHS standards. NMN was briefly under FDA scrutiny in the US but remains available as a supplement. The field is rapidly evolving with ongoing clinical trials.

Clinical Studies Summary

NMN Supplementation in Humans

Clinical trials showing oral NMN safely elevates blood NAD+ levels in healthy adults, with some evidence for improved insulin sensitivity and muscle function.

Science. 2022; Various clinical trial publicationsView on PubMed

NR (Niagen) Human Safety and Efficacy

Multiple trials demonstrating NR supplementation safely increases NAD+ metabolites in humans, with studies in ageing, metabolic health, and cardiovascular function.

Nature Communications. 2018View on PubMed

Looking for NAD+?

Source research-grade NAD+ from a trusted UK supplier — third-party tested with certificate of analysis.

View at Supplier

Frequently Asked Questions

Questions to ask a qualified clinician about NAD+

These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.

Is there a clinical reason to elevate NAD+ for my specific situation, or is this a wellness experiment?

UK regulatory & safety context

Clinic claim red flags

Safety Centre guide

Related Research Guides

Peptides for Anti-Ageing

Read guide

Related Peptides

Epitalon

A synthetic tetrapeptide based on epithalamin, researched for its potential effects on telomerase activation and biological ageing.

Learn more

MOTS-c

A mitochondrial-derived peptide that regulates metabolic homeostasis and exercise adaptations, representing a novel class of signalling molecules.

Learn more

Humanin

A mitochondrial-derived peptide with cytoprotective and anti-apoptotic properties, researched for neuroprotection, metabolic regulation, and ageing.

Learn more

SS-31

A mitochondria-targeted tetrapeptide in clinical trials for heart failure, mitochondrial myopathy, and age-related mitochondrial dysfunction.

Learn more

Explore More Peptides

Browse our comprehensive database of research-backed peptide profiles.

Fact-checked by the Peptide Authority Editorial Board · Last reviewed: 8 March 2026

Share:X Post LinkedIn

Longevity & Anti-Ageing•Updated 2026-03-08•5 min read

What Is NAD+? Benefits, Research & Safety

An essential coenzyme involved in cellular energy production and DNA repair, central to ageing research and available as IV infusions and oral precursor supplements.

Share:X Post LinkedIn

Also known as:

Nicotinamide Adenine Dinucleotide

NAD

Coenzyme I

DPN

CLimited human evidenceUK: Sold as 'research only' (UK)WADA: Low sport risk

Quick Facts

Overview

Evidence standards summary

NAD+ — evidence and risk at a glance

01Evidence snapshot

CLimited human evidenceOverall grade against our evidence grading methodology.

02Human evidence grade

CLimited human evidenceStrength of evidence from published human trials.

03Preclinical evidence grade

AStrong human evidenceAnimal-model and in-vitro evidence quality.

04Regulatory status

UK: NAD+ precursors (NMN, NR) are available as food supplements. IV NAD+ available at private clinics (not NHS-funded).
EU: NR is available as a supplement. NMN regulatory status varies by country—classified as Novel Food in some jurisdictions.
Notes: NAD+ and its precursors are not classified as medicines. IV NAD+ therapy is available privately but not evidence-based by NHS standards. NMN was briefly under FDA scrutiny in the US but remains available as a supplement. The field is rapidly evolving with ongoing clinical trials.

05Approved medical uses

None in the UK or EU as a finished medicine. (Or: not yet documented; treat as absence rather than approval.)

06Unapproved / promotional claims

Reverses biological ageing.
Treats long COVID.
Cures chronic fatigue.

07Common internet claims

Marketed by IV-drip clinics at £200-500+ per infusion.
NMN / NR supplements widely sold as longevity precursors.

08Claim vs evidence

Claim	Evidence	Human evidence?	Regulatory concern	Safer wording
“Reverses biological ageing”	E	No	High	Animal studies show NAD restoration affects ageing-related markers; human ageing-reversal claims are not supported.
“IV drips are more effective than oral NMN”	D	Limited	Moderate	IV NAD+ raises blood NAD acutely; whether this drives the wellness outcomes claimed is not established. Oral NMN/NR is far cheaper for sustained elevation.
“Safe long-term”	C	Limited	Moderate	Short-term safety data are encouraging; long-term (5+ years) human safety is not established.

09Safety uncertainty score

Moderate

Safety profile partly characterised; some signals from observational or preclinical data.

10Known adverse signals

IV NAD+: flushing, nausea, chest pressure during infusion.
Theoretical cancer-pathway concerns with sustained NAD+ elevation (mixed signal).
Sterility issues with grey-market IV preparations.

11Drug-interaction uncertainty

Moderate

Some interaction data published; check with a prescriber for your specific medicines.

12Anti-doping status

WADA: Low sport riskWADA strict-liability framing applies.

13UK legal position

UK: Sold as 'research only' (UK)

NAD+ precursors (NMN, NR) are available as food supplements. IV NAD+ available at private clinics (not NHS-funded).

14EU legal position

NR is available as a supplement. NMN regulatory status varies by country—classified as Novel Food in some jurisdictions.

15What this page cannot tell you

Whether IV NAD+ produces any longevity / wellness benefit beyond the placebo and infusion-experience effect.
Long-term safety of sustained pharmacological NAD+ elevation.

16Last reviewed

Last reviewed: 8 March 2026

Next review due: 8 March 2027

Spotted an error or something out of date? Send a correction.

17Citation quality score

BModerate human evidenceQuality of the sources we cite, graded against the evidence grading methodology.

18Research gaps

Phase 3 longevity / disease-prevention outcome trials absent.
Oral vs IV comparative-effectiveness for any defined outcome.

19Safer alternatives / established care pathways

Exercise, sleep, Mediterranean diet — the evidence-based longevity interventions.
NHS investigation for genuine chronic fatigue / long-COVID concerns.

20Doctor discussion prompts

Questions to ask a qualified clinician

These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.

Is there a clinical reason to elevate NAD+ for my specific situation, or is this a wellness experiment?

Discovery & History

Mechanism of Action

Researched Benefits

Based on preclinical and clinical research findings:

1
Restored mitochondrial function in aged mice (preclinical)
2
Improved insulin sensitivity and metabolic parameters (animal studies)
3
Enhanced DNA repair capacity (preclinical)
4
Cardiovascular protection in animal models
5
Neuroprotection and cognitive improvement (animal studies)
6
Safe elevation of blood NAD+ levels in humans (clinical trials of NMN/NR)
7
Potential exercise performance enhancement (limited human data)

Claim vs Evidence

How popular claims about NAD+ stack up against the current research, graded using our public evidence grading methodology.

Claim	Evidence	Human evidence?	Regulatory concern	Safer wording
“Reverses biological ageing”	E	No	High	Animal studies show NAD restoration affects ageing-related markers; human ageing-reversal claims are not supported.
“IV drips are more effective than oral NMN”	D	Limited	Moderate	IV NAD+ raises blood NAD acutely; whether this drives the wellness outcomes claimed is not established. Oral NMN/NR is far cheaper for sustained elevation.
“Safe long-term”	C	Limited	Moderate	Short-term safety data are encouraging; long-term (5+ years) human safety is not established.

Theoretical Dosing & Protocols

Theoretical Dosage	IV NAD+: 250-750mg per infusion. Oral NMN: 250-1000mg daily. Oral NR: 300-1000mg daily.
Frequency	IV: weekly to monthly sessions. Oral precursors: daily supplementation.
Duration	Ongoing; NAD+ levels decline without continued supplementation
Notes	NAD+ IV infusions are available at longevity clinics (expensive, £200-500+ per session). Oral precursors (NMN, NR) are available as food supplements without prescription. Quality varies significantly between products. Long-term human efficacy data for anti-ageing is still limited.

Administration Routes

Routes studied in research settings (educational only):

Intravenous infusion (IV NAD+)
Oral (NMN and NR precursor supplements)
Sublingual (some NMN formulations)
Intranasal (experimental)

Half-Life	Stability
NAD+ itself has a half-life of hours in circulation; tissue NAD+ pools are maintained by continuous synthesis	IV NAD+ solutions prepared fresh; NMN/NR supplements stable as dry powder

Safety Profile & Known Risks

Commonly Reported Side Effects

IV NAD+: nausea, cramping, chest tightness during infusion
Flushing and warmth (IV)
Headache
Mild GI discomfort with oral precursors
IV infusions can be uncomfortable (2-4 hour duration)

Rare Risks & Concerns

Theoretical concern about supporting tumour metabolism
Interaction with NAD+-dependent drug metabolism
Limited long-term safety data for high-dose supplementation
IV complications (standard IV risks)

Contraindications

Active cancer (theoretical concern about fuelling tumour metabolism)
Pregnancy and breastfeeding (insufficient safety data)
Concurrent use of NAD+-affecting medications

UK & EU Regulatory Context

🇬🇧 United Kingdom

NAD+ precursors (NMN, NR) are available as food supplements. IV NAD+ available at private clinics (not NHS-funded).

🇪🇺 European Union

NR is available as a supplement. NMN regulatory status varies by country—classified as Novel Food in some jurisdictions.

Clinical Studies Summary

NMN Supplementation in Humans

Clinical trials showing oral NMN safely elevates blood NAD+ levels in healthy adults, with some evidence for improved insulin sensitivity and muscle function.

Science. 2022; Various clinical trial publicationsView on PubMed

NR (Niagen) Human Safety and Efficacy

Multiple trials demonstrating NR supplementation safely increases NAD+ metabolites in humans, with studies in ageing, metabolic health, and cardiovascular function.

Nature Communications. 2018View on PubMed

Looking for NAD+?

Source research-grade NAD+ from a trusted UK supplier — third-party tested with certificate of analysis.

View at Supplier

Frequently Asked Questions

Questions to ask a qualified clinician about NAD+

These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.

Is there a clinical reason to elevate NAD+ for my specific situation, or is this a wellness experiment?